A decision-making algorithm for remote digital assessments of Alzheimer's Disease
DISCUSSION: We suggest that the use of screening questionnaires in the context of Memory clinics may help accelerating the adoption of remote digital assessment in everyday clinical practice.PMID:38688254 | DOI:10.1159/000539129 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - April 30, 2024 Category: Neurology Authors: Valeria Manera Clair Vandersteen Alexandra Plonka Constance Lafontaine Kevin Galery Alexandre Derreumaux Nouha Ben Gaied Aur élie Mouton Guillaume Sacco Cyrille Launay Olivier Gu érin Philippe Robert Gilles Allali Kim Sawchuk Olivier Beauchet Auriane Gr Source Type: research
A decision-making algorithm for remote digital assessments of Alzheimer's Disease
DISCUSSION: We suggest that the use of screening questionnaires in the context of Memory clinics may help accelerating the adoption of remote digital assessment in everyday clinical practice.PMID:38688254 | DOI:10.1159/000539129 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - April 30, 2024 Category: Neurology Authors: Valeria Manera Clair Vandersteen Alexandra Plonka Constance Lafontaine Kevin Galery Alexandre Derreumaux Nouha Ben Gaied Aur élie Mouton Guillaume Sacco Cyrille Launay Olivier Gu érin Philippe Robert Gilles Allali Kim Sawchuk Olivier Beauchet Auriane Gr Source Type: research
A decision-making algorithm for remote digital assessments of Alzheimer's Disease
DISCUSSION: We suggest that the use of screening questionnaires in the context of Memory clinics may help accelerating the adoption of remote digital assessment in everyday clinical practice.PMID:38688254 | DOI:10.1159/000539129 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - April 30, 2024 Category: Neurology Authors: Valeria Manera Clair Vandersteen Alexandra Plonka Constance Lafontaine Kevin Galery Alexandre Derreumaux Nouha Ben Gaied Aur élie Mouton Guillaume Sacco Cyrille Launay Olivier Gu érin Philippe Robert Gilles Allali Kim Sawchuk Olivier Beauchet Auriane Gr Source Type: research
A decision-making algorithm for remote digital assessments of Alzheimer's Disease
DISCUSSION: We suggest that the use of screening questionnaires in the context of Memory clinics may help accelerating the adoption of remote digital assessment in everyday clinical practice.PMID:38688254 | DOI:10.1159/000539129 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - April 30, 2024 Category: Neurology Authors: Valeria Manera Clair Vandersteen Alexandra Plonka Constance Lafontaine Kevin Galery Alexandre Derreumaux Nouha Ben Gaied Aur élie Mouton Guillaume Sacco Cyrille Launay Olivier Gu érin Philippe Robert Gilles Allali Kim Sawchuk Olivier Beauchet Auriane Gr Source Type: research
A decision-making algorithm for remote digital assessments of Alzheimer's Disease
DISCUSSION: We suggest that the use of screening questionnaires in the context of Memory clinics may help accelerating the adoption of remote digital assessment in everyday clinical practice.PMID:38688254 | DOI:10.1159/000539129 (Source: Neuro-Degenerative Diseases)
Source: Neuro-Degenerative Diseases - April 30, 2024 Category: Neurology Authors: Valeria Manera Clair Vandersteen Alexandra Plonka Constance Lafontaine Kevin Galery Alexandre Derreumaux Nouha Ben Gaied Aur élie Mouton Guillaume Sacco Cyrille Launay Olivier Gu érin Philippe Robert Gilles Allali Kim Sawchuk Olivier Beauchet Auriane Gr Source Type: research
Circulating Biomarkers for Alzheimer's Disease: Unlocking the diagnostic potential in Low-and Middle-Income Countries, focusing on Africa
Neurodegener Dis. 2024 Mar 29. doi: 10.1159/000538623. Online ahead of print.ABSTRACTBACKGROUND: Alzheimer's disease (AD) is emerging as a significant public health challenge in Africa, with predictions indicating a tripling in incidence by 2050. The diagnosis of AD on the African continent is notably difficult, leading to late detection that severely limits treatment options and significantly impacts the quality of life for patients and their families.SUMMARY: This review focuses on the potential of high-sensitivity specific blood biomarkers as promising tools for improving AD diagnosis and management globally, particular...
Source: Neuro-Degenerative Diseases - March 31, 2024 Category: Neurology Authors: Luc Nwamekang Belinga Jeanne Espourteille Yembe Wepnyu Njamnshi Ariole Zafack Zeukang Olivier Rouaud Alfred Kongnyu Njamnshi Gilles Allali Kevin Richetin Source Type: research
Circulating Biomarkers for Alzheimer's Disease: Unlocking the diagnostic potential in Low-and Middle-Income Countries, focusing on Africa
Neurodegener Dis. 2024 Mar 29. doi: 10.1159/000538623. Online ahead of print.ABSTRACTBACKGROUND: Alzheimer's disease (AD) is emerging as a significant public health challenge in Africa, with predictions indicating a tripling in incidence by 2050. The diagnosis of AD on the African continent is notably difficult, leading to late detection that severely limits treatment options and significantly impacts the quality of life for patients and their families.SUMMARY: This review focuses on the potential of high-sensitivity specific blood biomarkers as promising tools for improving AD diagnosis and management globally, particular...
Source: Neuro-Degenerative Diseases - March 31, 2024 Category: Neurology Authors: Luc Nwamekang Belinga Jeanne Espourteille Yembe Wepnyu Njamnshi Ariole Zafack Zeukang Olivier Rouaud Alfred Kongnyu Njamnshi Gilles Allali Kevin Richetin Source Type: research
Circulating Biomarkers for Alzheimer's Disease: Unlocking the diagnostic potential in Low-and Middle-Income Countries, focusing on Africa
Neurodegener Dis. 2024 Mar 29. doi: 10.1159/000538623. Online ahead of print.ABSTRACTBACKGROUND: Alzheimer's disease (AD) is emerging as a significant public health challenge in Africa, with predictions indicating a tripling in incidence by 2050. The diagnosis of AD on the African continent is notably difficult, leading to late detection that severely limits treatment options and significantly impacts the quality of life for patients and their families.SUMMARY: This review focuses on the potential of high-sensitivity specific blood biomarkers as promising tools for improving AD diagnosis and management globally, particular...
Source: Neuro-Degenerative Diseases - March 31, 2024 Category: Neurology Authors: Luc Nwamekang Belinga Jeanne Espourteille Yembe Wepnyu Njamnshi Ariole Zafack Zeukang Olivier Rouaud Alfred Kongnyu Njamnshi Gilles Allali Kevin Richetin Source Type: research
Circulating Biomarkers for Alzheimer's Disease: Unlocking the diagnostic potential in Low-and Middle-Income Countries, focusing on Africa
Neurodegener Dis. 2024 Mar 29. doi: 10.1159/000538623. Online ahead of print.ABSTRACTBACKGROUND: Alzheimer's disease (AD) is emerging as a significant public health challenge in Africa, with predictions indicating a tripling in incidence by 2050. The diagnosis of AD on the African continent is notably difficult, leading to late detection that severely limits treatment options and significantly impacts the quality of life for patients and their families.SUMMARY: This review focuses on the potential of high-sensitivity specific blood biomarkers as promising tools for improving AD diagnosis and management globally, particular...
Source: Neuro-Degenerative Diseases - March 31, 2024 Category: Neurology Authors: Luc Nwamekang Belinga Jeanne Espourteille Yembe Wepnyu Njamnshi Ariole Zafack Zeukang Olivier Rouaud Alfred Kongnyu Njamnshi Gilles Allali Kevin Richetin Source Type: research
Circulating Biomarkers for Alzheimer's Disease: Unlocking the diagnostic potential in Low-and Middle-Income Countries, focusing on Africa
Neurodegener Dis. 2024 Mar 29. doi: 10.1159/000538623. Online ahead of print.ABSTRACTBACKGROUND: Alzheimer's disease (AD) is emerging as a significant public health challenge in Africa, with predictions indicating a tripling in incidence by 2050. The diagnosis of AD on the African continent is notably difficult, leading to late detection that severely limits treatment options and significantly impacts the quality of life for patients and their families.SUMMARY: This review focuses on the potential of high-sensitivity specific blood biomarkers as promising tools for improving AD diagnosis and management globally, particular...
Source: Neuro-Degenerative Diseases - March 31, 2024 Category: Neurology Authors: Luc Nwamekang Belinga Jeanne Espourteille Yembe Wepnyu Njamnshi Ariole Zafack Zeukang Olivier Rouaud Alfred Kongnyu Njamnshi Gilles Allali Kevin Richetin Source Type: research
Circulating Biomarkers for Alzheimer's Disease: Unlocking the diagnostic potential in Low-and Middle-Income Countries, focusing on Africa
Neurodegener Dis. 2024 Mar 29. doi: 10.1159/000538623. Online ahead of print.ABSTRACTBACKGROUND: Alzheimer's disease (AD) is emerging as a significant public health challenge in Africa, with predictions indicating a tripling in incidence by 2050. The diagnosis of AD on the African continent is notably difficult, leading to late detection that severely limits treatment options and significantly impacts the quality of life for patients and their families.SUMMARY: This review focuses on the potential of high-sensitivity specific blood biomarkers as promising tools for improving AD diagnosis and management globally, particular...
Source: Neuro-Degenerative Diseases - March 31, 2024 Category: Neurology Authors: Luc Nwamekang Belinga Jeanne Espourteille Yembe Wepnyu Njamnshi Ariole Zafack Zeukang Olivier Rouaud Alfred Kongnyu Njamnshi Gilles Allali Kevin Richetin Source Type: research
Circulating Biomarkers for Alzheimer's Disease: Unlocking the diagnostic potential in Low-and Middle-Income Countries, focusing on Africa
Neurodegener Dis. 2024 Mar 29. doi: 10.1159/000538623. Online ahead of print.ABSTRACTBACKGROUND: Alzheimer's disease (AD) is emerging as a significant public health challenge in Africa, with predictions indicating a tripling in incidence by 2050. The diagnosis of AD on the African continent is notably difficult, leading to late detection that severely limits treatment options and significantly impacts the quality of life for patients and their families.SUMMARY: This review focuses on the potential of high-sensitivity specific blood biomarkers as promising tools for improving AD diagnosis and management globally, particular...
Source: Neuro-Degenerative Diseases - March 31, 2024 Category: Neurology Authors: Luc Nwamekang Belinga Jeanne Espourteille Yembe Wepnyu Njamnshi Ariole Zafack Zeukang Olivier Rouaud Alfred Kongnyu Njamnshi Gilles Allali Kevin Richetin Source Type: research
Circulating Biomarkers for Alzheimer's Disease: Unlocking the diagnostic potential in Low-and Middle-Income Countries, focusing on Africa
Neurodegener Dis. 2024 Mar 29. doi: 10.1159/000538623. Online ahead of print.ABSTRACTBACKGROUND: Alzheimer's disease (AD) is emerging as a significant public health challenge in Africa, with predictions indicating a tripling in incidence by 2050. The diagnosis of AD on the African continent is notably difficult, leading to late detection that severely limits treatment options and significantly impacts the quality of life for patients and their families.SUMMARY: This review focuses on the potential of high-sensitivity specific blood biomarkers as promising tools for improving AD diagnosis and management globally, particular...
Source: Neuro-Degenerative Diseases - March 31, 2024 Category: Neurology Authors: Luc Nwamekang Belinga Jeanne Espourteille Yembe Wepnyu Njamnshi Ariole Zafack Zeukang Olivier Rouaud Alfred Kongnyu Njamnshi Gilles Allali Kevin Richetin Source Type: research
Circulating Biomarkers for Alzheimer's Disease: Unlocking the diagnostic potential in Low-and Middle-Income Countries, focusing on Africa
Neurodegener Dis. 2024 Mar 29. doi: 10.1159/000538623. Online ahead of print.ABSTRACTBACKGROUND: Alzheimer's disease (AD) is emerging as a significant public health challenge in Africa, with predictions indicating a tripling in incidence by 2050. The diagnosis of AD on the African continent is notably difficult, leading to late detection that severely limits treatment options and significantly impacts the quality of life for patients and their families.SUMMARY: This review focuses on the potential of high-sensitivity specific blood biomarkers as promising tools for improving AD diagnosis and management globally, particular...
Source: Neuro-Degenerative Diseases - March 31, 2024 Category: Neurology Authors: Luc Nwamekang Belinga Jeanne Espourteille Yembe Wepnyu Njamnshi Ariole Zafack Zeukang Olivier Rouaud Alfred Kongnyu Njamnshi Gilles Allali Kevin Richetin Source Type: research
Circulating Biomarkers for Alzheimer's Disease: Unlocking the diagnostic potential in Low-and Middle-Income Countries, focusing on Africa
Neurodegener Dis. 2024 Mar 29. doi: 10.1159/000538623. Online ahead of print.ABSTRACTBACKGROUND: Alzheimer's disease (AD) is emerging as a significant public health challenge in Africa, with predictions indicating a tripling in incidence by 2050. The diagnosis of AD on the African continent is notably difficult, leading to late detection that severely limits treatment options and significantly impacts the quality of life for patients and their families.SUMMARY: This review focuses on the potential of high-sensitivity specific blood biomarkers as promising tools for improving AD diagnosis and management globally, particular...
Source: Neuro-Degenerative Diseases - March 31, 2024 Category: Neurology Authors: Luc Nwamekang Belinga Jeanne Espourteille Yembe Wepnyu Njamnshi Ariole Zafack Zeukang Olivier Rouaud Alfred Kongnyu Njamnshi Gilles Allali Kevin Richetin Source Type: research
